Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry
- PMID: 32103498
- DOI: 10.1111/bjh.16427
Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry
Abstract
A retrospective analysis of presentation clinical, laboratory and immunophenotypic features of 1 081 patients with paroxysmal nocturnal haemoglobinuria (PNH) clones [glycosylphosphatidylinositol (GPI)-deficient blood cells] identified at our hospital by flow cytometry over the past 25 years was undertaken. Three distinct clusters of patients were identified and significant correlations between presentation disease type and PNH clone sizes were evident. Smaller PNH clones predominate in cytopenic and myelodysplastic subtypes; large PNH clones were associated with haemolytic, thrombotic and haemolytic/thrombotic subtypes. Rare cases with an associated chronic myeloproliferative disorder had either large or small PNH clones. Cytopenia was a frequent finding, highlighting bone marrow failure as the major underlying feature associated with the detection of PNH clones in the peripheral blood. Red cell PNH clones showed significant correlations between the presence of type II (partial GPI deficiency) red cells and thrombotic disease. Haemolytic PNH was associated with type III (complete GPI deficiency) red cell populations of >20%. Those with both haemolytic and thrombotic features had major type II and type III red cell populations. Distinct patterns of presentation age decade were evident for clinical subtypes with a peak incidence of haemolytic PNH in the 30-49 year age group and a biphasic age distribution for the cytopenia group.
Keywords: aplastic anaemia; flow cytometry; haemolytic anaemia; paroxysmal nocturnal haemoglobinuria; thrombosis.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.
Comment in
-
PNH phenotypes and their genesis.Br J Haematol. 2020 Jun;189(5):802-805. doi: 10.1111/bjh.16473. Epub 2020 Mar 12. Br J Haematol. 2020. PMID: 32166737 No abstract available.
References
-
- Alfinito, F., Del Vecchio, L., Rocco, S., Boccuni, P., Musto, P. & Rotoli, B. (1996) Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone. Leukemia, 10, 1326-1330.
-
- Arber, D.A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M.J., Le Beau, M.M., Bloomfield, C.D., Cazzola, M. & Vardiman, J.W. (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127, 2391-2406.
-
- Barrett, J., Saunthararajah, Y. & Molldrem, J. (2000) Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Seminars in Hematology, 37, 15-29.
-
- Bates, I. (2017) Reference ranges and normal values. In Dacie and Lewis Practical Haematology (ed. by B.J. Bain, I. Bates, M.A. Laffan,12th edn, pp. 8-17. Elsevier, London.
-
- Griscelli-Bennaceur, A., Gluckman, E., Scrobohaci, M.L., Jonveaux, P., Vu, T., Bazarbachi, A., Carosella, E.D., Sigaux, F. & Socié, G. (1995) Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood, 85, 1354-1363.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
